🇺🇸 aMIL in United States

20 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alanine Aminotransferase Increased — 2 reports (10%)
  2. Alopecia — 2 reports (10%)
  3. Anaemia — 2 reports (10%)
  4. Anxiety — 2 reports (10%)
  5. Application Site Exfoliation — 2 reports (10%)
  6. Aspartate Aminotransferase Increased — 2 reports (10%)
  7. Asthenia — 2 reports (10%)
  8. Back Pain — 2 reports (10%)
  9. Blood Creatinine Increased — 2 reports (10%)
  10. Blood Disorder — 2 reports (10%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is aMIL approved in United States?

aMIL does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for aMIL in United States?

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is the originator. The local marketing authorisation holder may differ — check the official source linked above.